Search - tctmd.com

Displaying 1 - 20 of 99

Sort: Relevancy | Date

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

Presentation TCT 2025

HOPE Registry: Updates on the 3 year results of BTK subset analyses

Presenter: Edward Tieng Chek Choke

October 28, 2025

Presentation TCT 2025

TCT 199: Use of the Esprit BTK Biodegradable Stent Scaffold for Recurrent Coronary In-stent Restenosis

Presenter: Bilal M. Murad

October 28, 2025

Presentation TCT 2025

TCT 914: Impact of Visual Estimation versus Quantitative Coronary Angiography of Diameter Stenosis on Clinical Outcomes in the LIFE-BTK Trial

Presenter: Hector M. Garcia-Garcia

October 27, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Lesion Preparation Throwdown: BTK Cases When I like Specialty Balloons

Presenter: Michael Cyrus Siah

October 26, 2025

Presentation TCT 2025

Lesion Preparation Throwdown: BTK Cases When I use Atherectomy?

Presenter: Anvar Babaev

October 26, 2025

Presentation TCT 2025

Lesion Preparation Throwdown – BTK Cases When I Use Javelin or IVL?

Presenter: John Winscott

October 26, 2025

Presentation TCT 2025

State of the Art BTK Drug Delivery: Do We Know What Works and When Will We Have the Evidence?

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

DCBs BTK – Where are They Now? (Current Update)

Presenter: Eric A. Secemsky

October 26, 2025

Presentation TCT 2025

BTK Scaffolds – From Esprit to Reflow: What Does it Mean to Be a Scaffold (Case Examples)?

Presenter: S. Jay Mathews

October 26, 2025

Presentation TCT 2024

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

Presenter: Sahil Parikh

October 29, 2024

Presentation TCT 2024

TCT 519: Impact of Intravascular Imaging on Clinical Outcomes in the LIFE-BTK Randomized Controlled Trial

Presenter: Hector Garcia-Garcia

October 29, 2024

Presentation TCT 2024

Esprit™ BTK System Device & Data Overview, Real-World Case Discussion and Patient Selection

Presenter: Ethan Korngold

October 28, 2024

Presentation TCT 2024

BTK Drug Coated Balloons: 1 Year After LIFE BTK – We Need Them More Than Ever

Presenter: Peter Schneider

October 28, 2024

Presentation TCT 2024

BTK and BTA: How is Promise II and DVA Making an impact?

Presenter: Anahita Dua

October 28, 2024

Presentation TCT 2024

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Presenter: Brian DeRubertis

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Presenter: Richard Pin

October 27, 2024

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Advertisement

Insights into PAD Pathogenesis from LIFE-BTK Substudies

HOPE Registry: Updates on the 3 year results of BTK subset analyses

TCT 199: Use of the Esprit BTK Biodegradable Stent Scaffold for Recurrent Coronary In-stent Restenosis

TCT 914: Impact of Visual Estimation versus Quantitative Coronary Angiography of Diameter Stenosis on Clinical Outcomes in the LIFE-BTK Trial

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Lesion Preparation Throwdown: BTK Cases When I like Specialty Balloons

Lesion Preparation Throwdown: BTK Cases When I use Atherectomy?

Lesion Preparation Throwdown – BTK Cases When I Use Javelin or IVL?

State of the Art BTK Drug Delivery: Do We Know What Works and When Will We Have the Evidence?

DCBs BTK – Where are They Now? (Current Update)

BTK Scaffolds – From Esprit to Reflow: What Does it Mean to Be a Scaffold (Case Examples)?

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

TCT 519: Impact of Intravascular Imaging on Clinical Outcomes in the LIFE-BTK Randomized Controlled Trial

Esprit™ BTK System Device & Data Overview, Real-World Case Discussion and Patient Selection

BTK Drug Coated Balloons: 1 Year After LIFE BTK – We Need Them More Than Ever

BTK and BTA: How is Promise II and DVA Making an impact?

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Exemplary Cases From the LIFE-BTK Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content